Work

Aberrant Phosphorylation of MEF2C Is Dispensable for Hematopoiesis, and Induces Chemotherapy Resistance and Susceptibility to MARK Kinase Inhibition Therapy in Acute Myeloid Leukemia

Year: 2016

Type: article

Source: Blood

DOI: 10.1182/blood.v128.22.436.436

Authors: Fiona C Brown, Eric Still, Paolo Cifani, Casie Reed, Scott Ficarro, Jie He, Richard Koche, Patrick Bhola, Peter Romanienko, Willie Mark, Andrei V. Krivtsov, Anthony Letai, Nathanael Gray, Jarrod Marto, Scott A. Armstrong, Alex Kentsis

Institutions: Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Foundation Medicine (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2627090460

FWCI:

Cites:

Cited by:

Related to: 10